Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity

Movement DisordersEarly View LETTERS: NEW OBSERVATION Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity Brook Huxford MSc, Brook Huxford MSc orcid.org/0000-0002-5908-6983 Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United KingdomSearch for more papers by this authorTahrina Haque BSc, Tahrina Haque BSc Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorAaron Ben Joseph MBBS, Aaron Ben Joseph MBBS Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United KingdomSearch for more papers by this authorCristina Simonet, Cristina Simonet MD orcid.org/0000-0002-5555-0283 Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorDavid Gallagher MRCP, PhD, David Gallagher MRCP, PhD Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorCaroline Budu BSc, DipPSY, Caroline Budu BSc, DipPSY Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorRuth Dobson MRCP, PhD, Ruth Dobson MRCP, PhD orcid.org/0000-0002-2993-585X Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorAlastairJ. Noyce MRCP, PhD, Corresponding Author AlastairJ. Noyce MRCP, PhD a.noyce@qmul.ac.uk orcid.org/0000-0003-3027-5497 Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom Royal London Hospital, Barts Health NHS Trust, London, United Kingdom Correspondence to: Dr. Alastair J. Noyce, Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, EC1M 6BQ; E-mail: a.noyce@qmul.ac.ukSearch for more papers by this author Brook Huxford MSc, Brook Huxford MSc orcid.org/0000-0002-5908-6983 Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United KingdomSearch for more papers by this authorTahrina Haque BSc, Tahrina Haque BSc Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorAaron Ben Joseph MBBS, Aaron Ben Joseph MBBS Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United KingdomSearch for more papers by this authorCristina Simonet, Cristina Simonet MD orcid.org/0000-0002-5555-0283 Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorDavid Gallagher MRCP, PhD, David Gallagher MRCP, PhD Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorCaroline Budu BSc, DipPSY, Caroline Budu BSc, DipPSY Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorRuth Dobson MRCP, PhD, Ruth Dobson MRCP, PhD orcid.org/0000-0002-2993-585X Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom Royal London Hospital, Barts Health NHS Trust, London, United KingdomSearch for more papers by this authorAlastairJ. Noyce MRCP, PhD, Corresponding Author AlastairJ. Noyce MRCP, PhD a.noyce@qmul.ac.uk orcid.org/0000-0003-3027-5497 Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom Royal London Hospital, Barts Health NHS Trust, London, United Kingdom Correspondence to: Dr. Alastair J. Noyce, Preventive Neurology Unit, Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, EC1M 6BQ; E-mail: a.noyce@qmul.ac.ukSearch for more papers by this author First published: 13 October 2021 https://doi.org/10.1002/mds.28829 Relevant conflicts of interest/financial disclosures:: There are no conflicts of interest to disclose. Funding agencies:: B.H. is funded by a Wolfson Institute PhD Studentship. The East London PD project is funded in part by Cure Parkinson's. The Preventive Neurology Unit is funded by the Barts Charity. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Open Research DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request. Early ViewOnline Version of Record before inclusion in an issue RelatedInformation